 | | | | The result is a resounding win for the abortion rights movement in the first statewide electoral test since the U.S. Supreme Court overturned Roe v. Wade. | | | | | | The U.S. Centers for Disease Control and Prevention (CDC) is expected to ease its guidelines to control the spread of COVID-19, including in schools as soon as this week, CNN reported on Wednesday, citing sources familiar with the plan. | | | | | | President Joe Biden said on Wednesday the Supreme Court and Republicans are clueless about the power of American women as he signed a second executive order aimed at protecting abortion rights. | | | | | | Researchers have found that decay of tissues after death can be halted and cell functions restored based on early experiments in pigs that may eventually help increase the number of transplantable human organs. | | | | | | Shares in Danish drugmaker Novo Nordisk fell on Wednesday as news about its new obesity drug disappointed investors, even though the firm lifted its sales and operating profit forecasts for the year on strong first half results. | | | | | | UnitedHealth Group Inc , the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans, according to four people with knowledge of the matter. | | | | | | The European Medicines Agency (EMA) is recommending Novavax's COVID-19 vaccine carry a warning of the possibility of two types of heart inflammation, an added burden for a shot that has so far failed to win wide uptake. | | | | | | Moderna Inc on Wednesday maintained its full-year COVID-19 vaccine sales forecast of $21 billion as canceled orders from low- and middle-income nations through the COVAX program offset gains from new booster dose orders. | | | | | | Regeneron Pharmaceuticals said on Wednesday it expects demand for blockbuster eye drug Eylea to remain strong in the third quarter even in the face of emerging competition from rival drugs, sending the company's shares up nearly 8%. | | | | | | CVS Health Corp on Wednesday lifted its annual outlook for COVID-19-related revenue as it expects sales of over-the-counter coronavirus tests to more than double this year, sending shares up over 5%. | | | | | |
